Andre A. Konski
Fox Chase Cancer Center
Philadelphia
Pennsylvania
USA
Name/email consistency: high
- Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma. Konski, A.A., Winter, K., Cole, B.F., Ang, K.K., Fu, K.K. Head. Neck (2009)
- Developing a radiation error scoring system to monitor quality control events in a radiation oncology department. Konski, A., Movsas, B., Konopka, M., Ma, C., Price, R., Pollack, A. J. Am. Coll. Radiol (2009)
- Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Konski, A., Garcia, M., John, M., Krieg, R., Pinover, W., Myerson, R., Willett, C. Int. J. Radiat. Oncol. Biol. Phys. (2008)
- Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trial. Konski, A., Bhargavan, M., Owen, J., Paulus, R., Cooper, J., Fu, K.K., Ang, K., Watkins-Bruner, D. J. Med. Econ (2008)
- Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Konski, A.A., Cheng, J.D., Goldberg, M., Li, T., Maurer, A., Yu, J.Q., Haluszka, O., Scott, W., Meropol, N.J., Cohen, S.J., Freedman, G., Weiner, L.M. Int. J. Radiat. Oncol. Biol. Phys. (2007)
- Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?. Konski, A., Speier, W., Hanlon, A., Beck, J.R., Pollack, A. J. Clin. Oncol. (2007)
- Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma. Konski, A., Watkins-Bruner, D., Brereton, H., Feigenberg, S., Hanks, G. Cancer (2006)
- Does age matter in the selection of treatment for men with early-stage prostate cancer?. Konski, A., Eisenberg, D., Horwitz, E., Hanlon, A., Pollack, A., Hanks, G. Cancer (2006)
- Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14. Konski, A., Desilvio, M., Hartsell, W., Watkins-Bruner, D., Coyne, J., Scarantino, C., Janjan, N. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Konski, A., Watkins-Bruner, D., Feigenberg, S., Hanlon, A., Kulkarni, S., Beck, J.R., Horwitz, E.M., Pollack, A. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. Konski, A.A., Pajak, T.F., Movsas, B., Coyne, J., Harris, J., Gwede, C., Garden, A., Spencer, S., Jones, C., Watkins-Bruner, D. J. Clin. Oncol. (2006)
- Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. Konski, A., Hoffman, J., Sigurdson, E., Haluszka, O., Engstrom, P., Cheng, J.D., Cohen, S.J., Watson, J.C., Eisenberg, D., McGarrity, E., Freedman, G., Meropol, N.J. Semin. Oncol. (2005)
- Cost-effectiveness of intensity-modulated radiation therapy. Konski, A. Expert. Rev. Pharmacoecon. Outcomes. Res (2005)
